Susan G. Komen Kicks Off First Crowdfunding Campaign



At the end of September, Susan G. Komen announced $31 Million in 2017 funding for 98 new breast cancer research grants, with focus on aggressive and metastatic cancers.

Now the organization is asking the world to support metastatic breast cancer research through its first ever crowdfunding campaign.

In recognition of October being National Breast Cancer Awareness Month (NBCAM), the organization has pledged a dollar-for-dollar match from Odonate Therapeutics.

Odonate Therapeutics is focused on best-in-class therapeutics that improve and extend the lives of patients with cancer with an initial focus on the development of tesetaxel, a new orally-administered chemotherapy belonging to the taxane class.

Komen’s Bold Goal is to reduce current breast cancer deaths in the U.S. by 50% by 2026, and to date has invested more than $180 million toward metastatic breast cancer research, with more than 41% of Komen’s 2017 grants devoted to that research.

Odonate and an affiliated partner will match on a dollar-for-dollar basis all donations received between October 2, 2017 and December 31, 2017, up to a maximum of $1.5 million.

Odonate supports Komen’s newly-created Clinical Trials Information Helpline, 1-877-GO-KOMEN (1-877-465-6636), making the latest information available to those seeking help.

“Our donor community is passionate, invigorated and vitally interested in making a unique and lasting impact on breast cancer research,” said Komen interim President and CEO Ellen Willmott. “Likewise, our Komen-funded researchers are among the brightest and best in the world—we’re delighted to bring our community together with researchers through crowdfunding.”

Kevin Tang, Chairman and CEO Odonate Therapeutics added, “Odonate is dedicated to improving outcomes and quality of life for patients living with breast cancer, and we hope our partnership will encourage others to join us in supporting the vital mission of Susan G. Komen.”

Once the first four research grants are fulfilled, Komen will bring on additional researchers and donors will hear the researchers’ stories, learn about their work and better understand the impact that each researcher is making or hopes to make.

Those interested in supporting the crowdfunded grantees are encouraged to visit

Susan G. Komen is the world’s largest breast cancer organization and since launch in 1982 has funded more than $956 million in research and provided more than $2.1 billion in funding to screening, education, treatment and psychosocial support programs serving millions of people in more than 30 countries worldwide.